GB Sciences (GB Sciences) Operating Cash Flow per Share : $-0.00 (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is GB Sciences Operating Cash Flow per Share?

GB Sciences's operating cash flow per share for the three months ended in Dec. 2023 was $-0.00. GB Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 38.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 47.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 30.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for GB Sciences's Operating Cash Flow per Share or its related term are showing as below:

GBLX' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -74.4 Med: 29.35 Max: 71.7
Current: 38.3

During the past 13 years, GB Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 71.70% per year. The lowest was -74.40% per year. And the median was 29.35% per year.

GBLX's 3-Year OCF Growth Rate is ranked better than
85.67% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs GBLX: 38.30

GB Sciences Operating Cash Flow per Share Historical Data

The historical data trend for GB Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GB Sciences Operating Cash Flow per Share Chart

GB Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.05

-0.02

-0.01

GB Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of GB Sciences's Operating Cash Flow per Share

For the Biotechnology subindustry, GB Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GB Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GB Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GB Sciences's Price-to-Operating-Cash-Flow falls into.

GB Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

GB Sciences's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-1.527	/	357.721
	=	-0.00

GB Sciences's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.205	/	403.172
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

GB Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of GB Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

GB Sciences (GB Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (OTCPK:GBLX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

18C:Germany

Address

9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148

Website

https://www.gbsciences.com

GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

Executives

John C Poss	director, officer: Chief Executive Officer
Craig Ellins	director, 10 percent owner, officer: CEO	3035 EAST PATRICK LANE, SUITE 9, LAS VEGAS NV 89120
Lazarus Management Co Llc	10 percent owner	260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Israel Opportunities Fund Lllp	10 percent owner	C/O IBEX GP LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Investment Partners Lllp	10 percent owner	C/O IBEX INVESTORS LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Justin B Borus	10 percent owner	260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206